MX2018008529A - Virus de la tilapia de tipo ortomixo. - Google Patents

Virus de la tilapia de tipo ortomixo.

Info

Publication number
MX2018008529A
MX2018008529A MX2018008529A MX2018008529A MX2018008529A MX 2018008529 A MX2018008529 A MX 2018008529A MX 2018008529 A MX2018008529 A MX 2018008529A MX 2018008529 A MX2018008529 A MX 2018008529A MX 2018008529 A MX2018008529 A MX 2018008529A
Authority
MX
Mexico
Prior art keywords
virus
orthomyxo
tilapia
vaccine
virus vaccine
Prior art date
Application number
MX2018008529A
Other languages
English (en)
Inventor
Dishon Arnon
Tal Shlomit
Original Assignee
Abic Biological Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abic Biological Laboratories Ltd filed Critical Abic Biological Laboratories Ltd
Publication of MX2018008529A publication Critical patent/MX2018008529A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

El presente documento describe el aislamiento y caracterización de un virus de ARN de pez recientemente descubierto. También se describen métodos para la detección del virus aislado, una vacuna de virus atenuado vivo y una vacuna de virus inactivado.
MX2018008529A 2016-01-10 2017-01-10 Virus de la tilapia de tipo ortomixo. MX2018008529A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662276873P 2016-01-10 2016-01-10
US201662352570P 2016-06-21 2016-06-21
PCT/IL2017/050027 WO2017118989A1 (en) 2016-01-10 2017-01-10 Orthomyxo-like virus of tilapia

Publications (1)

Publication Number Publication Date
MX2018008529A true MX2018008529A (es) 2019-06-06

Family

ID=59274499

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018008529A MX2018008529A (es) 2016-01-10 2017-01-10 Virus de la tilapia de tipo ortomixo.

Country Status (6)

Country Link
EP (1) EP3400007A4 (es)
CN (1) CN108778324A (es)
BR (1) BR112018014042A2 (es)
CO (1) CO2018008288A2 (es)
MX (1) MX2018008529A (es)
WO (1) WO2017118989A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108624718A (zh) * 2018-06-20 2018-10-09 上海海洋大学 恒温实时检测罗非鱼湖病毒的rpa试剂盒及其专用引物和探针
CN112194710A (zh) * 2020-08-19 2021-01-08 佛山科学技术学院 罗非鱼湖病毒s8基因编码的重组蛋白、由其制备的抗体及应用
NL2028806B1 (en) * 2021-07-22 2022-06-03 Univ Northwest A&F Tilv-2 protein or gene encoding tilv-2 protein in preparation of subunit vaccine against tilapia lake virus
CN113718061B (zh) * 2021-09-30 2023-06-09 厦门海关技术中心 一种同时检测罗湖病毒和病毒性神经坏死病毒的双重rt-pcr的引物组，试剂盒和方法
CN113755645B (zh) * 2021-09-30 2023-06-09 厦门海关技术中心 一种检测罗湖病毒的荧光定量rt-pcr引物对和探针，试剂盒和检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines
CN114057841A (zh) * 2014-12-15 2022-02-18 纽约市哥伦比亚大学理事会 新型罗非鱼病毒及其用途

Also Published As

Publication number Publication date
CO2018008288A2 (es) 2018-08-21
BR112018014042A2 (pt) 2019-02-12
EP3400007A1 (en) 2018-11-14
EP3400007A4 (en) 2019-08-28
WO2017118989A1 (en) 2017-07-13
CN108778324A (zh) 2018-11-09

Similar Documents

Publication Publication Date Title
MX2018008529A (es) Virus de la tilapia de tipo ortomixo.
MX2020013153A (es) Metodos y composiciones para inducir inmunidad protectora contra la infeccion por virus de inmunodeficiencia humana.
MX2018008413A (es) Virus oncolitico modificado.
EA201691993A1 (ru) Вакцина к вирусу эпидемической диареи свиней
TW201613558A (en) Novel vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus
CO2017007105A2 (es) Nuevos virus de tilapia
EP3995573A4 (en) PROTEOLYTIC TARGETED VIRUS, LIVE VACCINE THEREOF, METHOD FOR ITS PRODUCTION AND ITS USE
NZ739260A (en) Inactivated canine influenza vaccines and methods of making and uses thereof
CU24580B1 (es) Vectores atenuados de influenza para la prevención y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncológicas
MX2018006416A (es) Metodos para el tratamiento, prevencion y diagnostico de infeccion por el virus de la diarrea epidemica porcina.
MX2021009105A (es) Toxinas apxia, apxiia y apxiiia inactivadas.
MX2016012932A (es) Procedimientos novedosos para inducir una respuesta inmune.
PH12017501795B1 (en) Pestivirus vaccines for congenital tremors
MX2018014955A (es) Vacunas atenuadas vivas del virus de la influenza equina.
EA201792512A1 (ru) Составы для доставки антигенов респираторного синтициального вируса и норовируса в тонкий кишечник
MX2022012910A (es) Vacuna contra la bronquitis infecciosa.
WO2017106184A3 (en) Detection of live attenuated influenza vaccine viruses
EP3443077A4 (en) FAST PROCESS FOR GENERATING LIVE ATTENUATED VACCINES
EP3600404A4 (en) DEVELOPMENT OF ANOTHER LIVE MODIFIED INFLUENZA B VIRUS VACCINE
EP3852796A4 (en) VACCINE, METHOD OF VACCINATION AGAINST CLOSTRIDIUM DIFFICILE
MX2019014450A (es) Vacuna contra la enteritis necrotica en aves de corral.
WO2015120459A3 (en) Live, attenuated vaccines and methods of making and using
MX2020006327A (es) Deteccion de vacunas vivas modificadas contra el virus de la gripe porcina.
PH12017502378A1 (en) Inactivated canine influenza vaccines and methods of making and uses thereof
EA202090463A1 (ru) Системы и способы экстракции каучука и побочных продуктов